QQQ   425.65 (-0.04%)
AAPL   168.48 (+0.29%)
MSFT   409.21 (-0.64%)
META   500.64 (+1.31%)
GOOGL   155.44 (-0.02%)
AMZN   180.69 (-0.33%)
TSLA   151.89 (-2.29%)
NVDA   845.56 (+0.62%)
AMD   155.24 (+0.79%)
NIO   3.91 (+0.00%)
BABA   69.37 (+0.80%)
T   16.15 (+0.19%)
F   12.08 (+0.33%)
MU   115.55 (-0.67%)
GE   156.86 (+0.76%)
CGC   6.57 (+1.23%)
DIS   113.50 (+0.50%)
AMC   2.94 (-1.34%)
PFE   25.41 (-0.04%)
PYPL   63.56 (+0.47%)
XOM   119.60 (+0.82%)
QQQ   425.65 (-0.04%)
AAPL   168.48 (+0.29%)
MSFT   409.21 (-0.64%)
META   500.64 (+1.31%)
GOOGL   155.44 (-0.02%)
AMZN   180.69 (-0.33%)
TSLA   151.89 (-2.29%)
NVDA   845.56 (+0.62%)
AMD   155.24 (+0.79%)
NIO   3.91 (+0.00%)
BABA   69.37 (+0.80%)
T   16.15 (+0.19%)
F   12.08 (+0.33%)
MU   115.55 (-0.67%)
GE   156.86 (+0.76%)
CGC   6.57 (+1.23%)
DIS   113.50 (+0.50%)
AMC   2.94 (-1.34%)
PFE   25.41 (-0.04%)
PYPL   63.56 (+0.47%)
XOM   119.60 (+0.82%)
QQQ   425.65 (-0.04%)
AAPL   168.48 (+0.29%)
MSFT   409.21 (-0.64%)
META   500.64 (+1.31%)
GOOGL   155.44 (-0.02%)
AMZN   180.69 (-0.33%)
TSLA   151.89 (-2.29%)
NVDA   845.56 (+0.62%)
AMD   155.24 (+0.79%)
NIO   3.91 (+0.00%)
BABA   69.37 (+0.80%)
T   16.15 (+0.19%)
F   12.08 (+0.33%)
MU   115.55 (-0.67%)
GE   156.86 (+0.76%)
CGC   6.57 (+1.23%)
DIS   113.50 (+0.50%)
AMC   2.94 (-1.34%)
PFE   25.41 (-0.04%)
PYPL   63.56 (+0.47%)
XOM   119.60 (+0.82%)
QQQ   425.65 (-0.04%)
AAPL   168.48 (+0.29%)
MSFT   409.21 (-0.64%)
META   500.64 (+1.31%)
GOOGL   155.44 (-0.02%)
AMZN   180.69 (-0.33%)
TSLA   151.89 (-2.29%)
NVDA   845.56 (+0.62%)
AMD   155.24 (+0.79%)
NIO   3.91 (+0.00%)
BABA   69.37 (+0.80%)
T   16.15 (+0.19%)
F   12.08 (+0.33%)
MU   115.55 (-0.67%)
GE   156.86 (+0.76%)
CGC   6.57 (+1.23%)
DIS   113.50 (+0.50%)
AMC   2.94 (-1.34%)
PFE   25.41 (-0.04%)
PYPL   63.56 (+0.47%)
XOM   119.60 (+0.82%)
Free Trial
NASDAQ:SLXP

Salix Pharmaceuticals (SLXP) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)
Free SLXP Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
4.96 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SLXP stock logo

About Salix Pharmaceuticals Stock (NASDAQ:SLXP)

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders. The Company offers over 20 marketed products, such as XIFAXAN550 (rifaximin) tablets, XIFAXAN (rifaximin) tablets, APRISO (mesalamine) extended-release capsules, UCERIS (budesonide MMX) extended release tablets, MOVIPREP, GLUMETZA extended release tablets, RELISTOR subcutaneous injection, UCERIS rectal foam, OSMOPREP tablets, SOLESTA, DEFLUX, FULYZAQ (crofelemer) delayed-release tablets, GIAZO (balsalazide disodium) tablets, CYCLOSET (bromocriptine mesylate) tablets, and FENOGLIDE (fenofibrate) tablets, among others. Its primary product candidates under development include Rifaximin, Methylnaltrexone bromide oral, Ruconest, Rifaximin delayed release or extended intestinal release and Rifaximin soluble solid dispersion (SSD)/next generation.

SLXP Stock News Headlines

May 17, 2023 | benzinga.com
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
April 6, 2023 | bizjournals.com
Pharmaceuticals News
April 18, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
February 19, 2023 | thestreet.com
Why Salix Pharmaceuticals (SLXP) Stock Is Gaining Today
January 7, 2023 | thestreet.com
Salix Pharmaceuticals (SLXP) Stock Closed Lower Today as Valeant Looks to Increase Bid
December 31, 2022 | thestreet.com
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today
December 25, 2022 | thestreet.com
Why Salix Pharmaceuticals (SLXP) Stock Is Surging Today
December 23, 2022 | thestreet.com
Valeant Pharmaceuticals (VRX) Stock Surges Today as Analyst Ups Price Target on Salix Deal
April 18, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
September 9, 2022 | marketwatch.com
Bausch Health Says FDA Won't Fully Approve Generic Xifaxan Until 2029
September 4, 2022 | thestreet.com
Salix Acquisition Likely, but at What Price Is Open to Debate
July 28, 2022 | seekingalpha.com
Bausch Health plummets 50% following judge's Xifaxan patent order
July 18, 2022 | thestreet.com
DNDNQ News
June 20, 2022 | markets.businessinsider.com
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022
June 1, 2022 | thestreet.com
Jim Cramer's 'Mad Money' Recap: Calm Down, There's No Nasdaq Bubble
January 6, 2022 | thestreet.com
Stock Market Today: Futures Jump as Jobs Rebound in September
August 2, 2021 | finance.yahoo.com
Canada's Valeant to buy Salix in $10.1 billion deal
See More Headlines
Receive SLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Salix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SLXP
CUSIP
79543510
CIK
1009356
Web
www.salix.com
Phone
+1-919-8621000
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

SLXP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Salix Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Salix Pharmaceuticals investors own include Allergan (AGN), Baidu (BIDU), Gilead Sciences (GILD), (QIHU) (QIHU), Capri (CPRI), 3D Systems (DDD), Intercept Pharmaceuticals (ICPT), Johnson & Johnson (JNJ) and

This page (NASDAQ:SLXP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
IRS Loophole Gives Americans An Escape From Inflation
Birch Gold
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group